C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcγRI)

被引:63
作者
Bodman-Smith, KB
Melendez, AJ
Campbell, I
Harrison, PT
Allen, JM
Raynes, JG
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Immunol Unit, London WC1E 7HT, England
[2] Univ Glasgow, Dept Med & Therapeut, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland
关键词
D O I
10.1046/j.1365-2567.2002.01481.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
C-reactive protein (CRP) is the prototypic acute-phase protein in man which performs innate immune functions. CRP-mediated phagocytosis may be indirect, through activation of complement and complement receptors, or direct, through receptors for the Fc portion of immunoglobulin G (IgG; FcgammaRs) or even a putative CRP-specific receptor. No strong evidence has been shown to indicate which receptors may be responsible for phagocytosis or signalling responses. Using BIAcore technology, we confirm that CRP binds directly to the extracellular portion of FcgammaRI with a threefold higher affinity than IgG (K (D) = 0.81 x 10(-9) m). Binding is Ca2+ dependent and is inhibited by IgG1 but not by phosphorylcholine (PC). CRP opsonization (using CRP concentrations within the normal human serum range) of PC-conjugated sheep erythrocytes increased phagocytosis of these particles by COS-7 cells transfected with FcgammaRI-II chimaera or FcgammaRI/gamma-chain. Interferon-gamma-treated U937 cells, which signal through FcgammaRI to activate phospholipase D (PLD) in response to cross-linked IgG, were also activated by CRP without any requirement for further cross-linking. These studies indicate that CRP is capable of binding to and cross-linking FcgammaRI thereby resulting in PLD activation and increased phagocytosis. Uptake by FcgammaRI has been reported to promote various acquired immune responses suggesting that CRP could act in a similar way.
引用
收藏
页码:252 / 260
页数:9
相关论文
共 49 条
[31]   EXTRAHEPATIC TRANSCRIPTION OF HUMAN C-REACTIVE PROTEIN [J].
MURPHY, TM ;
BAUM, LL ;
BEAMAN, KD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (02) :495-498
[32]   FC-RECEPTORS [J].
RAVETCH, JV ;
KINET, JP .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :457-492
[33]   OPSONIC EFFECT OF C-REACTIVE PROTEIN ON PHAGOCYTOSIS AND INTRACELLULAR KILLING OF VIRULENT AND ATTENUATED STRAINS OF CANDIDA-ALBICANS BY HUMAN NEUTROPHILS [J].
RICHARDSON, MD ;
GRAY, CA ;
SHANKLAND, GS .
FEMS MICROBIOLOGY IMMUNOLOGY, 1991, 76 (06) :341-344
[34]   Inflammatory potential of C-reactive protein complexes compared to immune complexes [J].
Romero, IR ;
Morris, C ;
Rodriguez, M ;
Du Clos, TW ;
Mold, C .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 87 (02) :155-162
[35]   Human C-reactive protein does not bind to FcγRIIa on phagocytic cells [J].
Saeland, E ;
van Royen, A ;
Hendriksen, K ;
Vilé-Weekhout, H ;
Rijkers, GT ;
Sanders, LAM ;
van de Winkel, JGJ .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05) :641-642
[36]   MOLECULAR-CLONING OF THE CD2 ANTIGEN, THE T-CELL ERYTHROCYTE RECEPTOR, BY A RAPID IMMUNOSELECTION PROCEDURE [J].
SEED, B ;
ARUFFO, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) :3365-3369
[37]   Three dimensional structure of human C-reactive protein [J].
Shrive, AK ;
Cheetham, GMT ;
Holden, D ;
Myles, DAA ;
Turnell, WG ;
Volanakis, JE ;
Pepys, MB ;
Bloomer, AC ;
Greenhough, TJ .
NATURE STRUCTURAL BIOLOGY, 1996, 3 (04) :346-354
[38]   The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex [J].
Sondermann, P ;
Huber, R ;
Oosthuizen, V ;
Jacob, U .
NATURE, 2000, 406 (6793) :267-273
[39]   NATIVE HUMAN SERUM AMYLOID P-COMPONENT IS A SINGLE PENTAMER [J].
SORENSEN, IJ ;
ANDERSEN, O ;
NIELSEN, EH ;
SVEHAG, SE .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (03) :263-267
[40]   THE MAJOR ACUTE-PHASE REACTANTS - C-REACTIVE PROTEIN, SERUM AMYLOID-P COMPONENT AND SERUM AMYLOID-A PROTEIN [J].
STEEL, DM ;
WHITEHEAD, AS .
IMMUNOLOGY TODAY, 1994, 15 (02) :81-88